This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jones, T. R. Articles by Bigner, D. D. Search for Related Content PubMed PubMed Citation Articles by Jones, T. R. Articles by Bigner, D. D.

American Journal of Pathology, Vol 105, 316-327, Copyright © 1981 by American Society for Investigative Pathology

REGULAR ARTICLES

Anaplastic human gliomas grown in athymic mice. Morphology and glial fibrillary acidic protein expression

TR Jones, SH Bigner, SC Schold Jr, LF Eng and DD Bigner

The morphologic and biochemical characteristics of human surgical biopsy specimens taken from 17 patients with anaplastic human gliomas and of athymic mouse-grown tumors derived from them were examined. Fourteen were categorized as glioblastoma multiforme, one as an anaplastic astrocytoma, one as a recurrent glioblastoma multiforme, and one as a gliosarcoma. Fifteen of 17 tumors stained positively immunohistochemically for glial fibrillary acidic protein (GFAP), a glial-specific marker. When portions of the 17 surgical biopsy specimens were injected into the flank subcutaneous space of athymic mice, 16 produced tumors; different portions of a single biopsy specimen were used to establish three separate tumor lines; in toto, 18 tumor lines were established. Mouse-borne tumors contained various proportions of fibrillary and protoplasmic astrocytes, gemistocytes, small anaplastic cells, and multinucleated giant cells. Some were more homogeneous than the human tumors from which they were derived, while others contained a mixed population similar to that of the original biopsy specimen. Of these initial 18 tumors, 16 were stained for GFAP and 14 contained from fewer than 5% to almost 100% GFAP-expressing cells. Ten of the tumor lines were studied in serial passage, several demonstrating increased cellularity with increased passage. GFAP expression was followed through serial passage, and 7 of 10 tumor lines continued to express it, often in reduced amounts, and 2 of 10 ceased expression, one (the gliosarcoma) never having expressed it. These data demonstrate that while athymic mouse-borne human anaplastic gliomas retained some features of the human tumors from which they were derived, they varied from one another morphologically. These mouse- borne tumors also continued to evolve, often changing their levels of GFAP and demonstrating increased cellularity with passage.

This article has been cited by other articles:

				A. Giese, R. Bjerkvig, M.E. Berens, and M. Westphal Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment J. Clin. Oncol., April 15, 2003; 21(8): 1624 - 1636. [Abstract] [Full Text] [PDF]

				J. N. Rich, C. Guo, R. E. McLendon, D. D. Bigner, X.-F. Wang, and C. M. Counter A Genetically Tractable Model of Human Glioma Formation Cancer Res., May 1, 2001; 61(9): 3556 - 3560. [Abstract] [Full Text]

				L. Antunes, K. S. Angioi–Duprez, S. R. Bracard, N. A. Klein–Monhoven, A. E. Le Faou, A. M. Duprez, and F. M. Plénat Analysis of Tissue Chimerism in Nude Mouse Brain and Abdominal Xenograft Models of Human Glioblastoma Multiforme: What Does It Tell Us About the Models and About Glioblastoma Biology and Therapy? J. Histochem. Cytochem., June 1, 2000; 48(6): 847 - 858. [Abstract] [Full Text]